Caris Life Sciences, Inc. 4

Jeff L. Vacirca, an insider of Caris Life Sciences, Inc., bought 31,050 shares of common stock at about $16.15 per share on May 11, 2026.

On May 11, 2026, reporting person Jeff L. Vacirca purchased 31,050 shares of Caris Life Sciences, Inc. common stock in open-market transactions at a weighted average price of $16.149 per share, for an aggregate purchase of approximately $501,000. Following this purchase, his direct beneficial ownership increased to 49,671 shares of common stock. The filing notes that the shares were acquired in multiple trades within a narrow price range of $16.13 to $16.15 and that detailed trade-level information is available upon request, indicating a straightforward insider accumulation rather than a compensation-related award.

Filing Facts

CIK

2019410

Ticker

CAI

Form

4

Source Type

sec

Accession

0001724161-26-000005

Alert Tier

7